Bharat Parenterals Appoints Crisil as Monitoring Agency for Preferential Issue
Bharat Parenterals Ltd 路 Extra Ordinary General Meeting 路 13 Oct 2026, 8:55 pm
Bharat Parenterals Appoints Crisil as Monitoring Agency for Preferential Issue Bharat Parenterals Limited has issued a corrigendum to the notice for its Extraordinary General Meeting scheduled for 23rd Oct'26. Following BSE directives during the in-principle approval process for its proposed preferential issue of equity shares, the company disclosed that the issue size exceeds INR 100 crore. Consequently, under SEBI ICDR Regulations, Bharat Parenterals has appointed Crisil Ratings Limited as the monitoring agency to oversee the utilization of the preferential issue proceeds. All other details and resolutions in the EGM notice remain unchanged.
Original exchange filing (PDF)
More announcements from Bharat Parenterals Ltd
- Intimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd., a subsidiary company of Bharat Parenterals Limited. 路 05 Nov 2026
- Transcript of Earnings Conference Call of Q2FY27. 路 02 Nov 2026
- Audio Recording of Q2FY27 Earnings Conference Call. 路 30 Oct 2026
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 路 29 Oct 2026
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 路 29 Oct 2026
- Outcome of the Meeting of the Board of Director of Bharat Parenterals Limited held on October 29, 2026 路 29 Oct 2026
- Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026. 路 25 Oct 2026
- Revised Voting Result 路 25 Oct 2026
